Expression and characterization of SARS-CoV-2 proteins using recombinant vaccinia virus MVA-T7pol
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
München, Ludwig-Maximilians-Universität, Dissertation, 2022
- Schlagwort
-
SARS-CoV-2
Coronaviren
COVID-19
- Ereignis
-
Veröffentlichung
- (wo)
-
München
- (wer)
-
Universitätsbibliothek der Ludwig-Maximilians-Universität
- (wann)
-
2022
- Urheber
- Beteiligte Personen und Organisationen
-
Sutter, Gerd
- DOI
-
10.5282/edoc.30480
- URN
-
urn:nbn:de:bvb:19-304809
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Nan, Liangliang
- Sutter, Gerd
- Universitätsbibliothek der Ludwig-Maximilians-Universität
Entstanden
- 2022
Ähnliche Objekte (12)
In vivo evaluation of recombinant Vaccinia virus MVA delivering ancestral H9 hemagglutinin antigen of Avian Influenza virus
Characterization of Vaccinia virus MVA candidate vaccines mutated in viral genes modulating inflammasome activation
Characterization of recombinant Modified Vaccinia virus Ankara delivering African swine fever virus proteins
Characterization of recombinant Modified Vaccinia virus Ankara delivering Zika virus nonstructural proteins NS2B and NS3pro
Characterization of recombinant Modified Vaccinia virus Ankara expressing the Middle East respiratory syndrome coronavirus nucleocapsid protein
Characterization of a recombinant Modified Vaccinia Virus Ankara encoding a novel synthetic immunogen of human cytomegalovirus
Improving the cellular immunogenicity of recombinant Modified Vaccinia virus Ankara using green fluorescent protein as model system
Characterization of fetal protection by vaccination with recombinant Modified Vaccinia virus Ankara in a Zika virus mouse model
Characterization of a recombinant Modified Vaccinia virus Ankara expressing the severe acute respiratory syndrome virus 2 spike protein
Characterization of recombinant Modified Vaccinia virus Ankara for delivery of Middle East Respiratory Syndrome Coronavirus spike protein antigens
Repair of the Vaccinia virus genes B2R and B3R inhibits interferon production uponmodified Vaccinia virus Ankara infection
The early phase of the vaccinia virus replication induces cytokine gene expression in macrophages
In vivo evaluation of recombinant Vaccinia virus MVA delivering ancestral H9 hemagglutinin antigen of Avian Influenza virus
Characterization of Vaccinia virus MVA candidate vaccines mutated in viral genes modulating inflammasome activation
Characterization of recombinant Modified Vaccinia virus Ankara delivering African swine fever virus proteins
Characterization of recombinant Modified Vaccinia virus Ankara delivering Zika virus nonstructural proteins NS2B and NS3pro
Characterization of recombinant Modified Vaccinia virus Ankara expressing the Middle East respiratory syndrome coronavirus nucleocapsid protein
Characterization of a recombinant Modified Vaccinia Virus Ankara encoding a novel synthetic immunogen of human cytomegalovirus
Improving the cellular immunogenicity of recombinant Modified Vaccinia virus Ankara using green fluorescent protein as model system
Characterization of fetal protection by vaccination with recombinant Modified Vaccinia virus Ankara in a Zika virus mouse model
Characterization of a recombinant Modified Vaccinia virus Ankara expressing the severe acute respiratory syndrome virus 2 spike protein
Characterization of recombinant Modified Vaccinia virus Ankara for delivery of Middle East Respiratory Syndrome Coronavirus spike protein antigens
Repair of the Vaccinia virus genes B2R and B3R inhibits interferon production uponmodified Vaccinia virus Ankara infection
The early phase of the vaccinia virus replication induces cytokine gene expression in macrophages
In vivo evaluation of recombinant Vaccinia virus MVA delivering ancestral H9 hemagglutinin antigen of Avian Influenza virus
Characterization of Vaccinia virus MVA candidate vaccines mutated in viral genes modulating inflammasome activation
Characterization of recombinant Modified Vaccinia virus Ankara delivering African swine fever virus proteins
Characterization of recombinant Modified Vaccinia virus Ankara delivering Zika virus nonstructural proteins NS2B and NS3pro
Characterization of recombinant Modified Vaccinia virus Ankara expressing the Middle East respiratory syndrome coronavirus nucleocapsid protein
Characterization of a recombinant Modified Vaccinia Virus Ankara encoding a novel synthetic immunogen of human cytomegalovirus
Improving the cellular immunogenicity of recombinant Modified Vaccinia virus Ankara using green fluorescent protein as model system
Characterization of fetal protection by vaccination with recombinant Modified Vaccinia virus Ankara in a Zika virus mouse model
Characterization of a recombinant Modified Vaccinia virus Ankara expressing the severe acute respiratory syndrome virus 2 spike protein
Characterization of recombinant Modified Vaccinia virus Ankara for delivery of Middle East Respiratory Syndrome Coronavirus spike protein antigens
Repair of the Vaccinia virus genes B2R and B3R inhibits interferon production uponmodified Vaccinia virus Ankara infection